- Country: Guatemala
- Summary: Treprostinil Inhaler Solution 0.6 Mg/ml Ampoule% 2.9ml. Trademark Trexonil According to Amparo 01022-2022-00205 Igss Code: 75964 P. 2398/2025
- GTT Ref No: 124150933
- Deadline: 11 Aug 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 27410285
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Treprostinil Inhaler Solution 0.6 Mg/ml Ampoule% 2.9ml. Trademark Trexonil According to Amparo 01022-2022-00205 Igss Code: 75964 P. 2398/2025
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINTreprostinil Inhaler Solution 0.6 Mg/ml Ampoule% 2.9ml. Trademark Trexonil According to Amparo 01022-2022-00205 Igss Code: 75964 P. 2398/2025 - Guatemala Tender
The GUATEMALAN SOCIAL SECURITY INSTITUTE -IGSS-, a Government sector organization in Guatemala, has announced a new tender for Treprostinil Inhaler Solution 0.6 Mg/ml Ampoule% 2.9ml. Trademark Trexonil According to Amparo 01022-2022-00205 Igss Code: 75964 P. 2398/2025. This tender is published on GuatemalaTenders under GTT Ref No: 124150933 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-08-11.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
